BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 25586403)

  • 1. Subchronic administration of short-acting naltrexone has no effect on striatal dopamine transporter availability, food intake or body weight gain in rats.
    Zaaijer ER; de Bruin K; la Fleur SE; Goudriaan AE; van den Brink W; Booij J
    J Psychopharmacol; 2015 Mar; 29(3):344-8. PubMed ID: 25586403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of extended-release naltrexone on striatal dopamine transporter availability, depression and anhedonia in heroin-dependent patients.
    Zaaijer ER; van Dijk L; de Bruin K; Goudriaan AE; Lammers LA; Koeter MW; van den Brink W; Booij J
    Psychopharmacology (Berl); 2015 Jul; 232(14):2597-607. PubMed ID: 25757673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of chronic naltrexone treatment on food intake patterns and body weight in rats depend on their food deprivation status.
    De Tomasi EB; Juárez J
    Eur J Pharmacol; 2011 Jan; 650(1):261-7. PubMed ID: 20969849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naltrexone modulates dopamine release following chronic, but not acute amphetamine administration: a translational study.
    Jayaram-Lindström N; Guterstam J; Häggkvist J; Ericson M; Malmlöf T; Schilström B; Halldin C; Cervenka S; Saijo T; Nordström AL; Franck J
    Transl Psychiatry; 2017 Apr; 7(4):e1104. PubMed ID: 28440810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of naltrexone on food intake and body weight gain in olanzapine-treated rats.
    Kurbanov DB; Currie PJ; Simonson DC; Borsook D; Elman I
    J Psychopharmacol; 2012 Sep; 26(9):1244-51. PubMed ID: 22723540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of mesolimbic structures in short-term sodium depletion: in situ hybridization and ligand-binding analyses.
    Lucas LR; Grillo CA; McEwen BS
    Neuroendocrinology; 2003 Jun; 77(6):406-15. PubMed ID: 12845226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naltrexone does not prevent the weight gain and hyperphagia induced by the antipsychotic drug sulpiride in rats.
    Baptista T; Lacruz A; Acosta A; Colasante C; de Quijada M; de Mendoza S; Mendoza JM; Hernández L
    Appetite; 2000 Feb; 34(1):77-86. PubMed ID: 10744894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alcohol consumption is enhanced after naltrexone treatment.
    Juárez J; Eliana Bde T
    Alcohol Clin Exp Res; 2007 Feb; 31(2):260-4. PubMed ID: 17250617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naltrexone treatment produces dose-related effects on food and water intake but daily alcohol consumption is not affected.
    Juárez J; Barrios De Tomasi E
    Nutr Neurosci; 2008 Aug; 11(4):183-92. PubMed ID: 18681987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of naltrexone on food intake and body weight in Syrian hamsters depends on metabolic status.
    Jones JE; Corp ES
    Physiol Behav; 2003 Jan; 78(1):67-72. PubMed ID: 12536012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naltrexone suppresses ethanol intake in 6-hydroxydopamine-treated rats.
    Koistinen M; Tuomainen P; Hyytiä P; Kiianmaa K
    Alcohol Clin Exp Res; 2001 Nov; 25(11):1605-12. PubMed ID: 11707635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reductions in body weight following chronic central opioid receptor subtype antagonists during development of dietary obesity in rats.
    Cole JL; Leventhal L; Pasternak GW; Bowen WD; Bodnar RJ
    Brain Res; 1995 Apr; 678(1-2):168-76. PubMed ID: 7620885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of oral buprenorphine, oral naltrexone or morphine on the effects of laparotomy in the rat.
    Liles JH; Flecknell PA; Roughan J; Cruz-Madorran I
    Lab Anim; 1998 Apr; 32(2):149-61. PubMed ID: 9587897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the incentive value of food after naltrexone treatment depend on a differential preference for a palatable food in male rats.
    Alvarado-Bañuelos M; Barrios De Tomasi E; Juárez J
    Nutr Neurosci; 2017 Sep; 20(7):416-423. PubMed ID: 28277185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of alcohol preference in high alcohol drinking rats: efficacy of amperozide versus naltrexone.
    Myers RD; Lankford MF
    Neuropsychopharmacology; 1996 Feb; 14(2):139-49. PubMed ID: 8822536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated administration of naltrexone and diprenorphine decreases food intake and body weight in squirrel monkeys.
    Herman BH; Holtzman SG
    Life Sci; 1984 Jan; 34(1):1-12. PubMed ID: 6319931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Divergent short- and long-term effects of acute stress in object recognition memory are mediated by endogenous opioid system activation.
    Nava-Mesa MO; Lamprea MR; Múnera A
    Neurobiol Learn Mem; 2013 Nov; 106():185-92. PubMed ID: 24036398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of amylin and bupropion/naltrexone on food intake and body weight are interactive in rodent models.
    Clapper JR; Athanacio J; Wittmer C; Griffin PS; D'Souza L; Parkes DG; Roth JD
    Eur J Pharmacol; 2013 Jan; 698(1-3):292-8. PubMed ID: 23178527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baclofen, raclopride, and naltrexone differentially affect intake of fat and sucrose under limited access conditions.
    Corwin RL; Wojnicki FH
    Behav Pharmacol; 2009 Sep; 20(5-6):537-48. PubMed ID: 19724193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of baclofen and naltrexone, alone and in combination, on the consumption of palatable food in male rats.
    Avena NM; Bocarsly ME; Murray S; Gold MS
    Exp Clin Psychopharmacol; 2014 Oct; 22(5):460-7. PubMed ID: 25069013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.